John F. Gerecitano, MD, PhD

Hematologic Oncologist

Clinical Director of Lymphoma Outpatient Services

Conditions Treated:

John F. Gerecitano, MD, PhD

About Me

I am a medical oncologist/hematologist who is a member of a close-knit team that provides compassionate, multidisciplinary care to patients with lymphoma. I have clinical expertise in Hodgkin Lymphoma, non-Hodgkin lymphoma and Chronic Lymphocytic Leukemia (CLL), and my research interests focus on finding new treatments for patients with these diseases. To accomplish this goal, I serve as the principal investigator on several clinical trials that evaluate promising new treatments from laboratories around the world. I have helped develop agents now approved to treat lymphoma and CLL, including bortezomib and ibrutinib. Many of my trials explore innovative ways to combine existing drugs with newer treatments in order to find novel ways to maximize responses while minimizing side effects in patients with lymphoma. I am also a member of the Developmental Therapeutics Group, a team of medical oncologists dedicated to providing access to the newest phase I agents for patients with all types of cancer throughout the Memorial Sloan Kettering.

Read more
  • Clinical Expertise: Hodgkin and Non-Hodgkin Lymphomas; Clinical Trials and New Drug Development in Lymphoma and Solid Tumors
  • Languages Spoken: English
  • Education: MD, PhD, New York University School of Medicine
  • Residencies: Hospital of the University of Pennsylvania
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Medical Oncology

Appointments Available

Making an appointment

Call 646-497-9137

See My Colleagues

Publications

Visit PubMed for a full listing of John F. Gerecitano’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.